-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CG1yMze+U2RaxPdUEasEwmq1Iof2pzzKh2VHXDZLYYDt+tqlglmUrFAfMyH6g52c Pjmz69QZ3K5vUIGWuGS6pw== 0001179110-06-011451.txt : 20060519 0001179110-06-011451.hdr.sgml : 20060519 20060519153529 ACCESSION NUMBER: 0001179110-06-011451 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050517 FILED AS OF DATE: 20060519 DATE AS OF CHANGE: 20060519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REILLY PHILIP R CENTRAL INDEX KEY: 0001237194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 06855237 MAIL ADDRESS: STREET 1: C/O INTERLEUKIN GENETICS INC STREET 2: 135 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02452 4 1 edgar.xml FORM 4 - X0202 4 2005-05-17 0 0001037649 INTERLEUKIN GENETICS INC ILI 0001237194 REILLY PHILIP R 135 BEAVER STREET WALTHAM MA 02452 1 0 0 0 Common Stock 2006-05-17 4 M 0 14000 0.50 A 24000 D Common Stock 2006-05-17 4 S 0 14000 5.64 D 10000 D Common Stock 2006-05-18 4 M 0 5500 0.50 A 15500 D Common Stock 2006-05-18 4 S 0 5500 5.48 D 10000 D Common Stock 73275 I See Footnote Option to Buy (Common Stock) 0.50 2005-05-17 4 M 0 14000 0.00 D 2000-01-01 2009-05-31 Common Stock 14000 175000 D Option to Buy (Common Stock) 0.50 2006-05-18 4 M 0 5500 0.00 A 2000-03-01 2009-05-31 Common Stock 5500 169500 D Pursuant to a 10b5-1 Trading Plan entered into on May 15, 2006. Shares are held in irrevocable trusts for the benefit of Dr. Reilly's children. Dr. Reilly disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purposes. 5,000 of these shares were exercisable on 1/1/00; 8,000 shares were exercisable on 2/1/00; and 1,000 were exercisable on 3/1/00. /s/ Philip R. Reilly 2006-05-19 -----END PRIVACY-ENHANCED MESSAGE-----